Jim Simons Werewolf Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 63,900 shares of HOWL stock, worth $77,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,900

Previous 56,900 12.3%

Holding current value

$77,319

Previous $84,000 27.38%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.97 - $1.68 $6,790 - $11,760	7,000 Added 12.3%	63,900 $61,000
Q4 2024 Feb 13, 2025	SELL	$1.48 - $3.63 $141,044 - $345,939	-95,300 Reduced 62.61%	56,900 $84,000
Q3 2024 Nov 13, 2024	SELL	$1.71 - $2.95 $32,148 - $55,460	-18,800 Reduced 10.99%	152,200 $322,000
Q2 2024 Aug 09, 2024	BUY	$2.34 - $6.75 $203,112 - $585,900	86,800 Added 103.09%	171,000 $417,000
Q1 2024 May 13, 2024	SELL	$3.92 - $7.91 $91,359 - $184,350	-23,306 Reduced 21.68%	84,200 $546,000
Q4 2023 Feb 13, 2024	BUY	$1.78 - $4.15 $110,904 - $258,569	62,306 Added 137.85%	107,506 $415,000
Q3 2023 Nov 14, 2023	BUY	$2.0 - $3.82 $4,600 - $8,786	2,300 Added 5.36%	45,200 $97,000
Q2 2023 Aug 11, 2023	BUY	$2.31 - $3.65 $20,328 - $32,120	8,800 Added 25.81%	42,900 $131,000
Q1 2023 May 12, 2023	SELL	$1.98 - $4.3 $87,363 - $189,728	-44,123 Reduced 56.41%	34,100 $89,000
Q4 2022 Feb 13, 2023	BUY	$1.53 - $4.73 $91,682 - $283,435	59,923 Added 327.45%	78,223 $160,000
Q3 2022 Nov 14, 2022	BUY	$4.14 - $7.42 $6,209 - $11,130	1,500 Added 8.93%	18,300 $83,000
Q2 2022 Aug 12, 2022	BUY	$3.43 - $5.98 $57,624 - $100,464	16,800 New	16,800 $69,000

Others Institutions Holding HOWL

# of Institutions

Shares Held

27.4M

Call Options Held

300

Put Options Held

13.6K

View Full List

About Werewolf Therapeutics, Inc.

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $35.7M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

More about HOWL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account